Profile | GDS4284 / 207686_s_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 775.471 | 70 |
GSM687648 | Patient 402 control | 572.236 | 66 |
GSM687653 | Patient 403 control | 948.379 | 74 |
GSM687658 | Patient 404 control | 653.844 | 68 |
GSM687663 | Patient 411 control | 1046.38 | 74 |
GSM687668 | Patient 422 control | 904.514 | 72 |
GSM687673 | Patient 424 control | 858.074 | 71 |
GSM687678 | Patient 425 control | 954.928 | 72 |
GSM687683 | Patient 427 control | 849.917 | 71 |
GSM687688 | Patient 428 control | 554.285 | 65 |
GSM687695 | Patient 441 control | 1089.3 | 76 |
GSM687699 | Patient 443 control | 1317.16 | 78 |
GSM687704 | Patient 444 control | 361.968 | 59 |
GSM687707 | Patient 448 control | 1503.66 | 80 |
GSM687712 | Patient 449 control | 753.185 | 70 |
GSM687719 | Patient 450 control | 823.027 | 70 |
GSM687724 | Patient 451 control | 902.396 | 73 |
GSM687728 | Patient 452 control | 1247.91 | 78 |
GSM687646 | Patient 401 treated 24h | 1045.83 | 74 |
GSM687649 | Patient 402 treated 24h | 1361.45 | 78 |
GSM687665 | Patient 411 treated 24h | 1309.66 | 78 |
GSM687651 | Patient 402 treated 4 weeks | 975.685 | 73 |
GSM687667 | Patient 411 treated 4 weeks | 1699.33 | 81 |
GSM687670 | Patient 422 treated 24h | 1128.9 | 75 |
GSM687671 | Patient 422 treated 4 weeks | 1471.75 | 79 |
GSM687654 | Patient 403 treated 24h | 863.833 | 72 |
GSM687675 | Patient 424 treated 24h | 1108.45 | 75 |
GSM687685 | Patient 427 treated 24h | 808.489 | 71 |
GSM687656 | Patient 403 treated 4 weeks | 1049.85 | 75 |
GSM687677 | Patient 424 treated 4 weeks | 540.505 | 64 |
GSM687687 | Patient 427 treated 4 weeks | 1146.75 | 76 |
GSM687692 | Patient 428 treated 4h | 841.906 | 71 |
GSM687716 | Patient 449 treated 4h | 711.264 | 69 |
GSM687722 | Patient 450 treated 4h | 813.618 | 71 |
GSM687680 | Patient 425 treated 24h | 903.373 | 72 |
GSM687690 | Patient 428 treated 24h | 432.94 | 62 |
GSM687700 | Patient 443 treated 24h | 874.809 | 71 |
GSM687705 | Patient 444 treated 24h | 383.339 | 61 |
GSM687714 | Patient 449 treated 24h | 781.234 | 71 |
GSM687721 | Patient 450 treated 24h | 942.994 | 73 |
GSM687682 | Patient 425 treated 4 weeks | 539.676 | 65 |
GSM687694 | Patient 428 treated 4 weeks | 773.816 | 70 |
GSM687702 | Patient 443 treated 4 weeks | 731.263 | 68 |
GSM687718 | Patient 449 treated 4 weeks | 645.94 | 68 |
GSM687723 | Patient 450 treated 4 weeks | 669.895 | 68 |
GSM687661 | Patient 404 treated 4h | 592.579 | 66 |
GSM687710 | Patient 448 treated 4h | 1198.51 | 77 |
GSM687726 | Patient 451 treated 4h | 1293.55 | 78 |
GSM687730 | Patient 452 treated 4h | 77.6535 | 18 |
GSM687660 | Patient 404 treated 24h | 595.572 | 67 |
GSM687697 | Patient 441 treated 24h | 1346.55 | 79 |
GSM687709 | Patient 448 treated 24h | 1564.15 | 81 |
GSM687725 | Patient 451 treated 24h | 997.326 | 74 |
GSM687729 | Patient 452 treated 24h | 1150.6 | 78 |
GSM687727 | Patient 451 treated 4 weeks | 942.909 | 73 |
GSM687731 | Patient 452 treated 4 weeks | 1365.69 | 78 |